CS logo
small CS logo
Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre

Clayton, Victoria, Australia
Research institute in Clayton, Victoria
45 Kanooka Grove, Clayton VIC 3168

About Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre


During the past decade, Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre


According to Clinical.Site data, the most researched conditions in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" are "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials), "MSA" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Parkinson's Disease (PD)" (1 trials). Many other conditions were trialed in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" in a lesser frequency.

Clinical Trials Intervention Types at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre


Most popular intervention types in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "ampreloxetine" (2 trials), "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Crizotinib" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre


The vast majority of trials in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre" are 4 trials for "All" genders.

Clinical Trials Status at Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre


Currently, there are NaN active trials in "Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Trials Centre, Level 3 Monash Health Translational Precinct Building Monash Medical Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".